Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Update Bahamas.
Press releases published on September 11, 2025
Bioxodes positive Phase 2a stroke data show breakthrough potential of innovative therapeutic candidate BIOX-101
GlobeNewswire
·
September 11, 2025
Safety endpoint met, with encouraging signs of efficacy in trial with 23 patients suffering from intracerebral hemorrhage (ICH) Findings suggest BIOX-101 reduced hematoma volume and slowed perihematomal edema growth Trend to functional recovery with BIOX- …
Les données positives de l’essai de phase 2a de Bioxodes montrent le fort potentiel de son candidat médicament innovant BIOX-101 dans l’AVC hémorragique
GlobeNewswire
·
September 11, 2025
Le critère de sécurité a été atteint et des signes encourageants d’efficacité ont été observés lors de l’essai mené auprès de 23 patients touchés par un AVC hémorragique Les résultats suggèrent que BIOX-101 réduit le volume de l'hématome et ralenti la …
US News & World Report-webinaret “New Frontiers in Kidney Care” fremhæver NGAL-biomarkøren
GlobeNewswire
·
September 11, 2025
11. september, 2025 Meddelelse US News …
US News & World Report Webinar “New Frontiers in Kidney Care” features NGAL biomarker
GlobeNewswire
·
September 11, 2025
September 11, 2025 News Release US News …
Scancell reports Business Update and Financial Results for the Year Ended 30 April 2025
GlobeNewswire
·
September 11, 2025
NOTTINGHAM, United Kingdom, Sept. 11, 2025 (GLOBE NEWSWIRE) -- Scancell Holdings plc (AIM: SCLP), the developer of ImmunoBody® and Moditope® active immunotherapies to treat cancer, today announces a business update and provides its final audited financial …
Press Release: Sanofi’s SAR402663 earns fast track designation in the US for neovascular age-related macular degeneration
GlobeNewswire
·
September 11, 2025
Sanofi’s SAR402663 earns fast track designation in the US for neovascular age-related macular degeneration Designation earned for a one-time intravitreal gene therapy with the potential to eliminate treatment burden for people living with neovascular age- …
Communiqué de presse : Le SAR402663 de Sanofi a obtenu la désignation « fast track » aux États-Unis pour le traitement de la dégénérescence maculaire liée à l’âge néovasculaire
GlobeNewswire
·
September 11, 2025
Le SAR402663 de Sanofi a obtenu la désignation « fast track » aux États-Unis pour le traitement de la dégénérescence maculaire liée à l’âge néovasculaire Désignation obtenue pour une thérapie génique intravitréenne unique avec le potentiel d’éliminer la …
Bioptimus Assembles Elite Scientific Advisory Board to Build Next-Gen AI Models for Biology
GlobeNewswire
·
September 11, 2025
PARIS, Sept. 11, 2025 (GLOBE NEWSWIRE) -- Bioptimus, the pioneering start-up building the world’s first universal foundation model for biology, today announced the formation of its Scientific Advisory Board (SAB), bringing together some of the most …
LB Pharmaceuticals Announces Pricing of its Upsized Initial Public Offering
GlobeNewswire
·
September 11, 2025
NEW YORK, Sept. 10, 2025 (GLOBE NEWSWIRE) -- LB Pharmaceuticals Inc (“LB Pharmaceuticals”) today announced the pricing of its upsized initial public offering of 19,000,000 shares of its common stock at a public offering price of $15.00 per share. The …